Eva Grunfeld1, David C Hodgson, M Elisabeth Del Giudice, Rahim Moineddin. 1. Ontario Institute for Cancer Research; Cancer Care Ontario Health Services Research Program; Department of Family and Community Medicine, University of Toronto; Institute of Clinical Evaluative Sciences, Sunnybrook Health Science Centre; Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
Abstract
PURPOSE: To describe the patterns of follow-up care provided to a population-based cohort of breast cancer survivors, and to assess factors associated with adherence to guidelines on follow-up care. PATIENTS AND METHODS: We conducted a retrospective longitudinal study of all women with surgically treated breast cancer who were without evidence of recurrence, advanced breast cancer, or new primary cancer and were diagnosed in Ontario, Canada, within a 2-year period (n = 11,219). They were followed for 5 years. The cohort was identified through the Ontario Cancer Registry, and individuals were linked across population-based administrative health databases. Frequency of and adherence to guideline recommendations for oncologist and primary care physician (PCP) visits; surveillance imaging for metastatic disease; and surveillance mammograms by year from diagnosis, age group, and income quintile were analyzed. Factors associated with adherence to guideline recommendations were analyzed. RESULTS: Most women saw both oncologists and PCPs in each follow-up year. Approximately two thirds had surveillance mammograms in each follow-up year. Overall, two thirds had either fewer or greater than recommended oncology visits, one quarter had fewer than recommended surveillance mammograms, and half had greater than recommended surveillance imaging for metastatic disease. CONCLUSION: This population-based study shows substantial variation in adherence to guideline recommendations, with both overuse and underuse of surveillance visits and tests. Most importantly, a substantial proportion are receiving more than recommended imaging for metastatic disease but fewer than recommended mammograms for detection of local recurrence or new primary cancer, for which effective intervention is possible.
PURPOSE: To describe the patterns of follow-up care provided to a population-based cohort of breast cancer survivors, and to assess factors associated with adherence to guidelines on follow-up care. PATIENTS AND METHODS: We conducted a retrospective longitudinal study of all women with surgically treated breast cancer who were without evidence of recurrence, advanced breast cancer, or new primary cancer and were diagnosed in Ontario, Canada, within a 2-year period (n = 11,219). They were followed for 5 years. The cohort was identified through the Ontario Cancer Registry, and individuals were linked across population-based administrative health databases. Frequency of and adherence to guideline recommendations for oncologist and primary care physician (PCP) visits; surveillance imaging for metastatic disease; and surveillance mammograms by year from diagnosis, age group, and income quintile were analyzed. Factors associated with adherence to guideline recommendations were analyzed. RESULTS: Most women saw both oncologists and PCPs in each follow-up year. Approximately two thirds had surveillance mammograms in each follow-up year. Overall, two thirds had either fewer or greater than recommended oncology visits, one quarter had fewer than recommended surveillance mammograms, and half had greater than recommended surveillance imaging for metastatic disease. CONCLUSION: This population-based study shows substantial variation in adherence to guideline recommendations, with both overuse and underuse of surveillance visits and tests. Most importantly, a substantial proportion are receiving more than recommended imaging for metastatic disease but fewer than recommended mammograms for detection of local recurrence or new primary cancer, for which effective intervention is possible.
Authors: Gregory S Cooper; Christine Cole Johnson; Lois Lamerato; Laila M Poisson; Lonni Schultz; Jan Simpkins; Karen Wells; Marianne Ulcickas Yood; Gary Chase; S David Nathanson; Jennifer Elston Lafata Journal: Med Care Date: 2006-06 Impact factor: 2.983
Authors: T J Smith; N E Davidson; D V Schapira; E Grunfeld; H B Muss; V G Vogel; M R Somerfield Journal: J Clin Oncol Date: 1999-03 Impact factor: 44.544
Authors: Jeanne S Mandelblatt; William F Lawrence; Jennifer Cullen; Annette L Stanton; Janice L Krupnick; Lorna Kwan; Patricia A Ganz Journal: J Clin Oncol Date: 2006-01-01 Impact factor: 44.544
Authors: Craig C Earle; Ann B Nattinger; Arnold L Potosky; Kathleen Lang; Rajiv Mallick; Mark Berger; Joan L Warren Journal: Med Care Date: 2002-08 Impact factor: 2.983
Authors: Patricia A Ganz; Erin E Hahn; Laura Petersen; Michelle E Melisko; John P Pierce; Marlene Von Friederichs-Fitzwater; Karen T Lane; Robert A Hiatt Journal: Clin Breast Cancer Date: 2016-05-14 Impact factor: 3.225
Authors: Caitlin C Murphy; Simon J Craddock Lee; David E Gerber; John V Cox; Hannah M Fullington; Robin T Higashi Journal: Patient Educ Couns Date: 2019-06-20
Authors: Abhishek D Parmar; Kristin M Sheffield; Gabriela M Vargas; Yimei Han; Celia Chao; Taylor S Riall Journal: Surgery Date: 2013-08 Impact factor: 3.982
Authors: Anna Jansana; Margarita Posso; Inmaculada Guerrero; Alexandra Prados-Torres; Maria Isabel Del Cura; Xavier Castells; Maria Sala Journal: J Cancer Surviv Date: 2019-04-09 Impact factor: 4.442
Authors: J Y Y Kwan; J Croke; T Panzarella; K Ubhi; A Fyles; A Koch; R Dinniwell; W Levin; D McCready; C Chung; F Liu; J L Bender Journal: Curr Oncol Date: 2019-04-01 Impact factor: 3.677
Authors: C Kendell; K M Decker; P A Groome; M L McBride; L Jiang; M K Krzyzanowska; G Porter; D Turner; R Urquhart; M Winget; E Grunfeld Journal: Curr Oncol Date: 2017-04-27 Impact factor: 3.677
Authors: Erin E Hahn; Patricia A Ganz; Michelle E Melisko; John P Pierce; Marlene von Friederichs-Fitzwater; Karen T Lane; Robert A Hiatt Journal: J Cancer Surviv Date: 2013-03-15 Impact factor: 4.442
Authors: Melissa Y Carpentier; Jasmin A Tiro; Lara S Savas; L Kay Bartholomew; Trisha V Melhado; Sharon P Coan; Keith E Argenbright; Sally W Vernon Journal: J Cancer Surviv Date: 2012-12-18 Impact factor: 4.442